PECAM-1 polymorphism affects monocyte adhesion to endothelial cells

Transplantation

Volumn 85, Issue 3, 2008, Pages 471-477

  Goodman, Reyna S ^a   Kirton, Christopher M ^b   Oostingh, Gertie J ^c   Schön, Michael P ^c   Clark, Michael R ^b   Bradley, J Andrew ^d   Taylor, Craig J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

CD31; Cell adhesion; PECAM 1; Polymorphism

Indexed keywords

CD31 ANTIGEN;

ARTICLE; CELL ADHESION; CELL CULTURE; CYTOLOGY; ENDOTHELIUM CELL; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; METABOLISM; MONOCYTE;

ANTIGENS, CD31; CELL ADHESION; CELLS, CULTURED; ENDOTHELIAL CELLS; GENOTYPE; HUMANS; MONOCYTES; POLYMORPHISM, GENETIC;

EID: 41149140879     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181622d65     Document Type: Article

References (33)

1. Albelda SM, Muller WA, Buck CA, Newman PJ. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule. J Cell Biol 1991; 114: 1059.
2. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178: 449.
3. Solowiej A, Biswas P, Graesser D, Madri JA. Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am J Pathol 2003; 162: 953.
4. Noble KE, Wickremasinghe RG, DeCornet C, et al. Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis. J Immunol 1999; 162: 1376.
5. Jackson DE, Kupcho KR, Newman PJ. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. J Biol Chem 1997; 272: 24868.
6. Kirschbaum NE, Gumina RJ, Newman PJ. Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain. Blood 1994; 84: 4028.
7. Newman PJ. Switched at birth:Anew family for PECAM-1. J Clin Invest 1999; 103: 5.
8. Newman PJ, Berndt MC, Gorski J, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990; 247: 1219.
9. Newman PJ. The biology of PECAM-1. J Clin Invest 1997; 99: 3.
10. Sun J, Williams J, Yan HC, et al. Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1and2anddependsonthe cytoplasmicdomainandthe level of surface expression. J Biol Chem 1996; 271: 18561.
11. Gumina RJ, Kirschbaum NE, Rao PN, et al. The human PECAM1 gene maps to 17q23. Genomics 1996; 34: 229.
12. Novinska MS, Pietz BC, Ellis TM, et al. The alleles of PECAM-1. Gene 2006; 376: 95.
13. Robbins FM, Hartzman RJ. CD31/PECAM-1 genotyping and haplotype analyses show population diversity. Tissue Antigens 2007; 69: 28.
14. Elrayess MA, Webb KE, Bellingan GJ, et al. R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD events. Atherosclerosis 2004; 177: 127.
15. Auer J, Weber T, Berent R, et al. Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am J Pharmacogenomics 2003; 3: 317.
16. Behar E, Chao NJ, Hiraki DD, et al. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N Engl J Med 1996; 334: 286.
17. Maruya E, Saji H, Seki S, et al. Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens inHLAidentical sibling bone marrow transplants. Blood 1998; 92: 2169.
18. Balduini CL, Frassoni F, Noris P, et al. Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. Br J Haematol 2001; 114: 951.
19. Grumet FC, Hiraki DD, Brown BWM, et al. CD31 mismatching affects marrow transplantation outcome. Biol Blood Marrow Transplant 2001; 7: 503.
20. Gratwohl A, Brand R, Apperley J, et al. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (CLWPEBMT). Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood 2002; 100: 3877.
21. Heinemann FM, Ferencik S, Ottinger HD, et al. Impact of disparity of minor histocompatibility antigens HA-1, CD31, and CD49b in hematopoietic stem cell transplantation of patients with chronic myeloid leukemia with sibling and unrelated donors. Transplantation 2004; 77: 1103.
22. Cavanagh G, Chapman CE, Carter V, et al. Donor CD31 genotype impacts on transplant complications after human leukocyte antigen-matched sibling allogeneic bone marrow transplantation. Transplantation 2005; 79: 602.
23. El-Chennawi FA, Kamel HA, Mosaad YM, et al. Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling. Hematology 2006; 11: 227.
24. Goodman RS, Ewing J, Evans PC, et al. Donor CD31 genotype and its association with acute graft-versus-host disease in HLA identical sibling stem cell transplantation. Bone Marrow Transplant 2005; 36: 151.
25. Oostingh GJ, Ludwig RJ, Enders S, et al. Diminished lymphocyte adhesion and alleviation of allergic responses by small-molecule- or antibody-mediated inhibition of L-selectin functions. J Invest Dermatol 2007; 127: 90.
26. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745.
27. Kirton CM, Nash GB. Activated platelets adherent to an intact endothelial cell monolayer bind flowing neutrophils and enable them to transfer to the endothelial surface. J Lab Clin Med 2000; 136: 303.
28. Kirton CM, Laukkanen ML, Nieminen A, et al. Function-blocking antibodies to human vascular adhesion protein-1: A potential anti-inflammatory therapy. Eur J Immunol 2005; 35: 3119.
29. von Andrian UH, Chambers JD, McEvoy LM, et al. Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc Natl Acad Sci U S A 1991; 88: 7538.
30. Piali L, Hammel P, Uherek C, et al. CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 1995; 130: 451.
31. Deaglio S, Morra M, Mallone R, et al. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol 1998; 160: 395.
32. Watt SM, Williamson J, Genevier H, et al. The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes. Blood 1993; 82: 2649.
33. Sun QH, DeLisser HM, Zukowski MM, et al. Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J Biol Chem 1996; 271: 11090.